Higher expression of FVIII (hematopoietic markers for megakaryocyte), CD117 (erythroid marker) and MPO (granulopoietic marker) was observed in the samples from mice developing breast cancer in comparison to controls (Figure 3). This evidence concerns the gene KIT and breast carcinoma.